Evaluation of platelet response (Complete Response) The time frame is up to 14 days per subject [clinicaltrials_resource:507e784609c7b6595eacfb7d2435c14c]
CR. A complete response (CR) was defined as a sustained (≥ 4 months) platelet count ≥ 100×109/L without recurrence of thrombocytopenia
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Evaluation of platelet response (Complete Response) The time frame is up to 14 days per subject [clinicaltrials_resource:507e784609c7b6595eacfb7d2435c14c]
CR. A complete response (CR) was defined as a sustained (≥ 4 months) platelet count ≥ 100×109/L without recurrence of thrombocytopenia
Bio2RDF identifier
507e784609c7b6595eacfb7d2435c14c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:507e784609c7b6595eacfb7d2435c14c
measure [clinicaltrials_vocabulary:measure]
Evaluation of platelet response (Complete Response)
time frame [clinicaltrials_vocabulary:time-frame]
The time frame is up to 14 days per subject
description
CR. A complete response (CR) w ...... recurrence of thrombocytopenia
identifier
clinicaltrials_resource:507e784609c7b6595eacfb7d2435c14c
title
Evaluation of platelet respons ...... e is up to 14 days per subject
@en
type
label
Evaluation of platelet respons ...... e784609c7b6595eacfb7d2435c14c]
@en